drug protocol number

OBS16040

drug sponsor

Sanofi

drug study

Toujeo

drug trial site

King Abdulaziz University Hospital (Jeddah), Alzafer Hospital (Najran), University District Hospital (Jeddah), Saudi German Hospital (Jeddah)

drug status

Ongoing

drug phase